Google
Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Clint Joiner, MD, PhD
Researcher Director of Hematology
Aflac Cancer and Blood Disorders Center
2015 Uppergate Drive
Atlanta, Georgia, United States
Dr. Clinton Joiner is a Director of Hematology at Aflac Cancer and Blood Disorders Center. Dr. Joiner was recruited to Emory in 2012 as Director of the Hematology Program in the Division of Hematology/Oncology. As a Professor of Pediatrics, he holds the Aflac Children’s Endowed Chair for Hematology. With nearly continuous funding by multiple NIH grants since 1984, Dr. Joiner’s basic research has focused on red blood cell physiology, specifically cell volume regulation and its abnormalities in sickle cell disease.
He has served on numerous NIH review panels, various program project reviews and the K23, K24 and K99 panels. Dr. Clinton Joiner has served on numerous advisory committees to NIH, industry groups and the Sickle Cell Disease Association of America. He currently serves as the Training Director of the Atlanta Pediatric Scholars Program (K12HD072245) that provides support for pediatricians at the junior faculty level who aim to develop funded research programs in basic and translational science.
Representative Publications:
KCl cotransport mediates abnormal sulfhydryl-dependent volume regulation in sickle reticulocytes
Dipyridamole inhibits sickling-induced cation fluxes in sickle red blood cells
The activation of KCL cotransport by deoxygenation and its role in sickle cell dehydration
+myBinderRelated Content
-
Russell Ware, MD, PhDRussell Ware, MD, PhD, has been involved...
-
Patients With Sickle Cell Disease may Have Lower Risk for C. DifficileFindings from a retrospective cohort stu...
-
Acute Care Utilization Is More Common in Patients with Sickle Cell Disease Who Have Chronic Complications and Chroni...Background: We undertook a large multisi...
-
Sam Rodgers-Melnick, MT-BCSamuel Rodgers-Melnick, MT-BC is a music...
-
MARAC Statement: Health Insurance Coverage for Hematopoietic Stem Cell Transplant for Sickle Cell Disease from HLA-m...Hematopoietic stem cell transplant for s...
-
U.S. Government Awards Missouri Researcher $4.3 Million to Study Sickle Cell in Teens, AdultsThe National Institutes of Health (NIH) ...
-
Physician Prescribing Practices in Sickle Cell DiseaseSickle cell disease (SCD) affects approx...
